Published in Drug Week, May 14th, 2004
The transaction is expected to provide net proceeds of $24.0 million to Cytogen.
CIBC World Markets Corp. acted as lead placement agent, with JMP Securities, LLC, and ThinkEquity Partners, LLC, acting as coplacement agents for this transaction.
The shares of common stock offered by Cytogen in this transaction were registered under the company's existing shelf registration...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.